Kestra Medical Technologies, Ltd. (KMTS): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$126.03M

Year ended 2026-04-30

-$134.18M

Trailing 12 months to 2026-07-31

2024-04-30 EBITDA (USD) 2026-04-30

Period ended	EBITDA	Change YoY	Source filing
2026-04-30	-$126.03M	n/m	2026-07-14, From 2025-05-01
2025-04-30	-$98.41M	n/m	2026-07-14, From 2024-05-01
2024-04-30	-$73.50M	n/a	2025-07-17, From 2023-05-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EBITDA	Change YoY
Kestra Medical Technologies, Ltd. (KMTS)	2026-04-30	-$126.03M	n/m
Iradimed Corp (IRMD)	2025-12-31	$27.31M	+19.9%
Anika Therapeutics, Inc. (ANIK)	2025-12-31	-$5.68M	n/m
Orasure Technologies Inc (OSUR)	2025-12-31	-$61.78M	n/m
PRO DEX Inc (PDEX)	2026-06-30	$14.38M	+20.6%
Sight Sciences, Inc. (SGHT)	2025-12-31	-$36.61M	n/m
AVITA Medical, Inc. (RCEL)	2025-12-31	-$40.19M	n/m
Xtant Medical Holdings, Inc. (XTNT)	2025-12-31	$12.51M	n/m
InfuSystem Holdings, Inc (INFU)	2025-12-31	$25.21M	+30.0%

Compare KMTS, IRMD, ANIK, OSUR side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗